======= CARD17 ======= == Gene Information == * **Official Symbol**: CARD17 * **Official Name**: caspase recruitment domain family member 17 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=440068|440068]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5XLA6|Q5XLA6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CARD17&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CARD17|Open PubMed]] * **OMIM**: N/A == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Regulator of procaspase-1/CASP1 activation implicated in the regulation of the proteolytic maturation of pro-IL-1beta/IL1B and its release during inflammation. Inhibits the release of IL1B in response to LPS in monocytes. However, unlike CASP1, do not induce NF-kappa-B activation. {ECO:0000269|PubMed:15383541}. |CARD| |caspase binding| |negative regulation of interleukin-1 beta secretion| |negative regulation of interleukin-1 secretion| |negative regulation of interleukin-1 beta production| |negative regulation of interleukin-1 production| |cysteine-type endopeptidase inhibitor activity| |regulation of interleukin-1 beta secretion| |regulation of interleukin-1 secretion| |negative regulation of cytokine secretion| |regulation of interleukin-1 beta production| |regulation of interleukin-1 production| |negative regulation of protein secretion| |negative regulation of peptide secretion| |negative regulation of protein transport| |cellular response to lipopolysaccharide| |negative regulation of establishment of protein localization| |cellular response to molecule of bacterial origin| |negative regulation of secretion by cell| |regulation of cytokine secretion| |cellular response to biotic stimulus| |negative regulation of secretion| |negative regulation of endopeptidase activity| |negative regulation of peptidase activity| |negative regulation of cytokine production| |response to lipopolysaccharide| |response to molecule of bacterial origin| |negative regulation of proteolysis| |regulation of endopeptidase activity| |regulation of peptidase activity| |negative regulation of hydrolase activity| |regulation of protein secretion| |negative regulation of transport| |regulation of peptide secretion| |cellular response to lipid| |protein-containing complex| |response to bacterium| |regulation of cytokine production| |regulation of protein transport| |regulation of proteolysis| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |negative regulation of catalytic activity| |regulation of secretion| |response to lipid| |regulation of protein localization| |negative regulation of cellular protein metabolic process| |cellular response to oxygen-containing compound| |identical protein binding| |negative regulation of protein metabolic process| |negative regulation of molecular function| |negative regulation of multicellular organismal process| |regulation of hydrolase activity| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |regulation of apoptotic process| |response to oxygen-containing compound| |regulation of programmed cell death| |regulation of cell death| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp47|Lapatinib 5μM R01 exp47]]|-2.1| |[[:results:exp61|YM155 0.0002μM R01 exp61]]|1.78| |[[:results:exp471|Cholesterol 0.003 to 0.006 to 0.1μM on day2 then day6 R08 exp471]]|1.98| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17926 * **Expression level (log2 read counts)**: -6.6 {{:chemogenomics:nalm6 dist.png?nolink |}}